Skip to main content
BIOXYNE LIMITED logo

BIOXYNE LIMITED — Investor Relations & Filings

Ticker · BXN ISIN · AU000000BXN6 LEI · 984500F02D2B1B94E956 ASX Manufacturing
Open in API
Filings indexed 844 across all filing types
Latest filing 2016-11-22 AGM Information
Country AU Australia
Listing ASX BXN

About BIOXYNE LIMITED

https://bioxyne.com

Bioxyne Limited is a life sciences company focused on the development, manufacture, and commercialization of health and wellness products. The company specializes in proprietary probiotic strains, notably the Lactobacillus fermentum VRI-003 (PCC), which is utilized in supplements targeting immune health and gut function. Following the acquisition of Breathe Life Sciences, Bioxyne has expanded its portfolio into the medicinal cannabis sector, novel foods, and consumer health products. Its operations encompass the production and distribution of pharmaceutical-grade cannabis products, CBD-based wellness items, and functional supplements. The company serves international markets through a vertically integrated model, focusing on research-driven formulations and high-quality manufacturing standards to address growing consumer demand for therapeutic and preventative health solutions.

Recent filings

Filing Released Lang Actions
AGM Notice - Amendment to Resolutions 2 pages 133.9KB
AGM Information Classification · 95% confidence The document is an ASX announcement dated 23 November 2016 regarding the Annual General Meeting (AGM) of Bioxyne Limited. It specifically mentions an amendment to resolutions for the AGM scheduled on 24 November 2016. The content focuses on notifying shareholders about a change in the resolutions to be voted on at the AGM, which is typical of an announcement related to AGM information. The document is short (2404 characters) and does not contain financial statements or detailed financial data, so it is not an Annual Report or Interim Report. It is not a voting results declaration, just an amendment notice before the meeting. Therefore, the most appropriate classification is AGM Information (AGM-R).
2016-11-22 English
AGM - Amendment to Resolutions 2 pages 134.8KB
AGM Information Classification · 95% confidence The document is an ASX announcement dated 21 November 2016 regarding an Annual General Meeting (AGM) of Bioxyne Limited. It specifically mentions an amendment to resolutions for the AGM and details about the meeting date and location. The content is about the AGM event and changes to resolutions, not the full AGM report or materials. The document length is short (2426 characters) and it is an announcement about the AGM rather than the AGM materials themselves. Therefore, it fits the category of AGM Information (AGM-R).
2016-11-20 English
Director Resignation 2 pages 137.1KB
Board/Management Information Classification · 100% confidence The document is an ASX announcement dated 18 November 2016 regarding a change in the company's board of directors. It specifically announces the resignation of a board member and mentions recent appointments to the board and management. There is no financial data, report, or detailed analysis present. The content fits the category of announcements about changes in the company's board or senior management. Therefore, the appropriate classification is 'Board/Management Information' (MANG). The document length is short and focused solely on management changes, confirming this classification with high confidence.
2016-11-17 English
Final Director's Interest Notice 2 pages 254.8KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Z Final Director’s Interest Notice' and references ASX listing rule 3.19A.3 and section 205G of the Corporations Act. It details the director's relevant interests in securities, including holdings and contracts, and notes the date the director ceased to be a director. The content is focused on reporting personal share transactions or holdings by a company director. This matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). The document length is short and specific to director interests, not a broader financial or management report.
2016-11-17 English
Launch of Two Products Containing PCC Onto Australian Market 2 pages 147.2KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 2 November 2016 from Bioxyne Limited about the launch of two probiotic products in the Australian market. It describes product details, clinical studies, and company background. There is no financial data, no regulatory filing references, no voting results, no management changes, no earnings or interim report data, and no mention of any report publication or certification. The content is a product launch announcement, which does not fit into any of the specific financial or regulatory filing categories. Therefore, the best fit is Regulatory Filings (RNS), which is the fallback category for miscellaneous announcements that do not fit other categories.
2016-11-01 English
Quarterly Activities Report and Appendix 4C 7 pages 229.5KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'QUARTERLY REPORT FOR THE PERIOD ENDED 30 SEPTEMBER 2016' and includes detailed financial data such as consolidated statements of cash flows, cash flow from operating, investing, and financing activities, and estimated cash outflows for the next quarter. It also references compliance with Listing Rule 4.7B and Australian Accounting Standards. The length of the document (11,962 characters) and the presence of substantive financial data confirm it is a full quarterly financial report rather than a brief announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2017
2016-10-25 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.